Nav: Home

Is your coffee contributing to malaria risk?

March 09, 2020

Researchers at the University of Sydney and University of São Paulo, Brazil, estimate 20 percent of the malaria risk in deforestation hot spots is driven by the international trade of exports including: coffee, timber, soybean, cocoa, wood products, palm oil, tobacco, beef and cotton.

"What does this mean for affluent consumers?" asks senior author Professor Manfred Lenzen, from the Centre for Integrated Sustainability Analysis in the School of Physics at University of Sydney. "We need to be more mindful of our consumption and procurement, and avoid buying from sources implicated with deforestation, and support sustainable land ownership in developing countries."

Previous studies have shown deforestation and rainforest disturbances can increase the transmission of malaria by creating conditions where mosquitoes thrive: warmer habitats and fewer predators.

The study, published in Nature Communications today, is the first to link global demand for goods that increase deforestation to a rise in malaria risk in humans.

"This study is the first to assess the role of global consumption in increasing deforestation and, in turn, malaria risk," said co-author Dr Arunima Malik, from the Centre for Integrated Sustainability Analysis in the School of Physics. "Unsustainable human consumption is clearly driving this trend."

Professor Lenzen said: "Directing consumption away from deforestation has benefits beyond the malaria link; it will help reducing biodiversity loss and greenhouse gas emissions as well."

Direct links

The authors of the study investigated links between the increasing risk of malaria in developing countries to products demanded by distant consumers.

"We achieved this by quantitatively relating malaria incidence first with deforestation, then to primary commodity production, which we then connected to global supply-chain networks and ultimately to worldwide consumer demand," Dr Malik said.

The final step was accomplished by coupling a highly detailed and large international database with an established and widely used analytical technique - multi-region input-output (MRIO) analysis.

"This work goes beyond simple incidence mapping and correlations, in that it unveils a global supply-chain network that links malaria occurring in specific locations because of deforestation with globally dispersed consumption," Dr Malik said.

A call for change

The results of the study can be used for more demand-side approaches to mitigating malaria incidence by focusing on regulating malaria-impacted global supply chains.

Demand-side initiatives such as product labelling and certification, supply-chain dialogue and green procurement standards have been successful in addressing trade-related global problems such as deforestation, threats to species and child labour.

Legal mechanisms can also be a good action to malaria control, said Dr Leonardo Chaves, a co-author of the study, in the Department of Epidemiology, School of Public Health, University of São Paulo, Brazil.

However, in Brazil, the agribusiness sector has criticised environmental legislation that obliges landowners to conserve a proportion of their land with native vegetation.

"If we lose this land to agricultural use we could greatly increase malaria risk, and the bill of each case of malaria in the Amazon is paid by poor and vulnerable families in this region," Dr Chaves said. "Development never reaches the small rural producer; it just makes illness."
-end-


University of Sydney

Related Malaria Articles:

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the Umeå University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.
Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.
New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
More Malaria News and Malaria Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.